-Reuters Citing Local Health Authorities
Piper Sandler Downgrades Shift Technologies to Neutral
Piper Sandler analyst Alexander Potter downgrades Shift Technologies (NASDAQ:SFT) from Overweight to Neutral.
Related Posts
Cardiff Oncology Presents Novel Preclinical Data At AACR Annual Meeting 2024; Supports First-Line RAS-Mutated mCRC Clinical Study
– In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor's ability to adapt to hypoxia resulting in a significant decrease in both tumor vascularization and
DoorDash Reports Mixed Q1 Results: EPS Miss, Sales Beat
DoorDash reports quarterly losses of 6 cents per share which missed the analyst consensus estimate of losses of 4 cents by 50%.
Nautilus Biotechnology Q3 EPS $(0.11) Beats $(0.15) Estimate
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 8.33 percent increase over losses of $(0.12) per share